NCT01695005 2025-12-26A Study of LY3039478 in Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed247 enrolled 53 charts
NCT02380313 2016-10-06Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or AibrateroneGlaxoSmithKlinePhase 1 Withdrawn
NCT00399087 2014-02-13Phase I Trial of Docetaxel With PerifosineAEterna ZentarisPhase 1 Completed39 enrolled